Morgan Stanley’s Core Scientific Inc Tranche 2 Warrants CORZZ Stock Holding History

Morgan Stanley’s Portfolio CORZZ Stock Details CORZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.92K	Sell	128 -105	-45%	-$1.79K	﹤0.01%	7339
2025 Q4	$3.39K	Sell	233 -4,795	-95%	-$83.7K	﹤0.01%	7138
2025 Q3	$90.2K	Sell	5,028 -13,186	-72%	-$193K	﹤0.01%	6200
2025 Q2	$313K	Sell	18,214 -31,465	-63%	-$313K	﹤0.01%	5667
2025 Q1	$357K	Hold	49,679	–	–	﹤0.01%	5483
2024 Q4	$696K	Hold	49,679	–	–	﹤0.01%	5279
2024 Q3	$584K	Hold	49,679	–	–	﹤0.01%	5327
2024 Q2	$432K	Buy	49,679 +43,395	+691%	+$166K	﹤0.01%	5358
2024 Q1	$15.1K	Buy	+6,284	New	+$15.5K	﹤0.01%	6569

Other funds holding CORZZ

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return

Fiduciary Alliance Greenville, South Carolina $1.48B AUM 24.99% 1-Year Est. Return

PWM

Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley's CORZZ Position: Q1 2026 in Review

Morgan Stanley reduced its Core Scientific Inc Tranche 2 Warrants (CORZZ) stake by 45% in Q1 2026, selling an estimated $1.79K and leaving 128 shares worth $1.92K. The position accounts for ﹤0.01% of the portfolio, ranked #7339.

Morgan Stanley first reported a position in CORZZ in Q1 2024 and has held it in 9 quarters since. The position peaked at $696K in Q4 2024. 29 funds tracked by Wall St. Rank hold CORZZ as of Q1 2026.

Morgan Stanley held 128 shares of Core Scientific Inc Tranche 2 Warrants worth $1.92K as of Q1 2026.
Morgan Stanley sold 105 Core Scientific Inc Tranche 2 Warrants shares in Q1 2026, an estimated $1.79K.
Core Scientific Inc Tranche 2 Warrants made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7339 holding.
Morgan Stanley first reported a position in Core Scientific Inc Tranche 2 Warrants in Q1 2024 and has held it in 9 quarters since.
Morgan Stanley's Core Scientific Inc Tranche 2 Warrants position peaked at $696K in Q4 2024.
29 funds tracked by Wall St. Rank held Core Scientific Inc Tranche 2 Warrants as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.